Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Author:
R. de Crevoisier,K. Slimane,T. Messai,P. Wibault,F. Eschwege,A. Bossi,S. Koscielny,A. Bridier,C. Massard,K. Fizazi
Publication:
Annals of Oncology
Copyright © 2009 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.